Human fetal islet transplantation in IDDM patients: an 8-year experience.
Dordević
P B
PB
Diabetes Center, Institute for Endocrinology, Belgrade, Yugoslavia.
Lalić
N M
NM
Brkić
S
S
Jotić
A
A
Paunović
I
I
Lalić
K
K
Dimitrijević
V
V
Dragasević
M
M
Zamaklar
M
M
Popović
S
S
D015415:Biomarkers; D002096:C-Peptide / Q000097:blood; D016516:CD4-CD8 Ratio; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery*; D016332:Fetal Tissue Transplantation / Q000009:adverse effects / Q000276:immunology / Q000502:physiology; D005934:Glucagon / Q000008:administration & dosage; D006442:Glycated Hemoglobin / Q000378:metabolism; D006084:Graft Rejection / Q000209:etiology; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000378:metabolism; D000078790:Insulin Secretion; D007376:Interleukin-2 / Q000097:blood; D016381:Islets of Langerhans Transplantation / Q000009:adverse effects / Q000276:immunology / Q000502:physiology; D013997:Time Factors
D015415:Biomarkers; D002096:C-Peptide; D005934:Glucagon; D006442:Glycated Hemoglobin; D007328:Insulin; D007376:Interleukin-2